| Document |
Document Title |
|
WO/2016/083399A1 |
The invention relates to a pharmaceutical composition comprising alpha-ketoglutarate, optionally a glutamate dehydrogenase, and optionally a cofactor for glutamate dehydrogenase. The composition according to the invention is particularly...
|
|
WO/2016/083399A9 |
The invention relates to a pharmaceutical composition comprising alpha-ketoglutarate, optionally a glutamate dehydrogenase, and optionally a cofactor for glutamate dehydrogenase. The composition according to the invention is particularly...
|
|
WO/2016/085290A1 |
The present invention relates to an antioxidant composition containing an extracellular polysaccharide produced using Ceriporia lacerata, or a mycelium culture of Ceriporia lacerata comprising the same, or a dry powder or an extract ther...
|
|
WO/2016/081826A3 |
The invention provides methods of treatment, pharmaceutical compositions, systems and kits appropriate for first line and/or adjunct therapy with antivenom using at least one active component, in some instances at least two active compon...
|
|
WO/2016/078148A1 |
An oral solution for detoxifying alcohol. The oral solution is prepared from raw materials comprising 10-14 parts of orange peels, 4-6 parts of fermented black beans, 2-6 parts of the white stalk of scallions, 2-8 parts of Brassica rapa ...
|
|
WO/2016/078155A1 |
A kidney-replenishing traditional Chinese medicine, for which traditional Chinese medicine raw materials used in the formula thereof by weight are: 10-12 grams of Chinese parsnip, 13-15 grams of Notopterygium incisum, 5-7 grams of ramulu...
|
|
WO/2016/079553A1 |
A composition to be administered to a patient to prevent harmful effects of biological venom or chemical toxin is described. The composition includes the use of the date palm, Phoenix dactylifera fruit to be administered to a patient at ...
|
|
WO/2016/080516A1 |
The present invention provides a pharmaceutical composition containing cilnidipine or a pharmaceutically acceptable salt thereof as an active ingredient. The present invention relates to: a dynamin-related protein 1 (Drp1) polymerization...
|
|
WO/2016/075700A1 |
A herbal composition and process for preparing a detoxifying herbal extract using the stem bark of the woody liana, Dalbergia horrida for treatment of snake bite specifically Cobra (Naja naja) and Russell's viper (Daboia russelli) in mam...
|
|
WO/2016/074203A1 |
The present invention relates to a cell apoptosis inducer containing chlorine dioxide. The present invention relates to a cell apoptosis inducer kit containing the following two independent components: the first component: a chlorine dio...
|
|
WO/2016/074336A1 |
An eaglewood sachet for baths. The eaglewood sachet is prepared through the following steps: washing 34-44 parts by weight of aquilaria sinensis, 24-34 parts by weight of incense tree and 24-34 parts by weight of agilawood, drying and mi...
|
|
WO/2016/072640A1 |
The present invention relates to a detoxifying composition containing a new green extract, which is a medicinal herb, as an active ingredient. Thus, toxicities in the human body can be efficiently removed without side effects by activati...
|
|
WO/2016/072496A1 |
The present invention relates to an agent for effectively suppressing an increase in blood-acetaldehyde concentration. More specifically, the present invention relates to an alcohol metabolism promoter containing glycogen obtained from a...
|
|
WO/2016/068439A1 |
The present invention relates to a food composition and a cosmetic composition for anti-oxidation, containing, as an active ingredient, black sticky rice with giant embryos, a pulverized product thereof or an extract thereof. The composi...
|
|
WO/2016/065409A1 |
The present invention provides a fusion polypeptide comprising a first domain and a second domain, wherein the first domain comprises a polypeptide ligand which binds to a cell surface-associated antigen and the second domain comprises a...
|
|
WO/2016/063671A1 |
Provided is an ellagic acid dispersion composition that contains: an aqueous medium; solid particles which contain ellagic acid and have an average particle diameter of 200 nm or less; and at least one type of surfactant selected from am...
|
|
WO/2016/061873A1 |
Liver-protecting sober-up tea and a preparation method therefor. The tea is prepared from 7-12 g of flowers of kudzuvine, 6-8 g of dendranthemamorifolium, 8-16 g of cassia seeds, 8-10 g of mung beans, 6-12 g of glycyrrhiza uralensis fisc...
|
|
WO/2016/065360A1 |
The disclosure provides thiol-containing alkyl fatty acid and vitamin D compound formulations for intravenous, parenteral or oral administration. The compositions of the present technology have optimal controlled bioavailability and are ...
|
|
WO/2016/062125A1 |
Disclosed is an anti-fatigue preparation, health care product or food using a reduced coenzyme II as an active component. The experiments show that it can obviously prolong the weight-bearing swimming time of a mouse, increase the reserv...
|
|
WO/2016/061872A1 |
Sober-up tea, prepared from the following materials by weight: 6-8 g of chrysanthemum, 8-16 g of mulberry leaves, 6-12 g of glycyrrhiza uralensis fisch, 7-12 g of biota orientalis, 5-8 g of salvia miltiorrhiza, 3-8 g of cortex phellodend...
|
|
WO/2016/058193A1 |
A traditional Chinese medicine composition for treating suboptimal health, and a preparation method for same, the components and parts by weight of the composition for treating suboptimal health being: 25-35 parts by weight Folium artemi...
|
|
WO/2016/061264A1 |
The present disclosure relates generally to conjugates and their uses and production. More particularly, it concerns conjugates comprising an A44 or K39 gingipain adhesin peptide, or fragment thereof (e.g., an A44/K39 peptide portion) co...
|
|
WO/2016/056648A1 |
The present invention addresses the problem of providing a simple and versatile method for stabilizing 2-O-α-D-glucosyl-L-ascorbic acid in an acidic aqueous medium. The problem is solved by providing a method for stabilizing 2-O-α-D-gl...
|
|
WO/2016/052656A1 |
An autophagy inducing agent that comprises at least one member selected from a compound represented by structural formula (A), a compound represented by structural formula (B), and a compound represented by structural formula (C).
|
|
WO/2016/053953A1 |
Provided are nutritional supplement preparations and methods for enhancing the outcome of a non-invasive tissue remodeling procedure, for providing the nutritional supplement to a subject, and for preparing such supplements. A synergisti...
|
|
WO/2016/051213A1 |
The present invention relates to a compound capable of inhibiting PAR by forming a supramolecular structure with PAR, for use in inhibiting PAR or for use in treating or preventing a disease susceptible to PAR inhibition. The present inv...
|
|
WO/2016/035790A1 |
The purpose of the present invention is to provide an erythrocyte function improving agent that has both high antioxidative effect and excellent migration ability to erythrocytes and is capable of effectively protecting erythrocytes agai...
|
|
WO/2016/031605A1 |
The present invention solves various problems associated with conventional external preparations used for ameliorating skin diseases which have been issues of concern. The purpose of the present invention is to provide an external prepar...
|
|
WO/2016/031651A1 |
Provided is a method for producing a solid dispersion whereby the solubility in water of a hardly soluble polyphenol can be improved. A method for producing a solid dispersion containing an amorphous hardly soluble polyphenol, said metho...
|
|
WO/2016/032448A1 |
The method of treating venomous bites, such as those from snakes and scorpions, involves treatment by the administration of a therapeutically effective amount of an aqueous extract of the fruit of Juniperus phoenicea, or pharmaceutically...
|
|
WO/2016/032924A1 |
The present disclosure is directed to random, acrylic co-polymers that are useful in transdermal applications. Methods of making and using the described co-polymers are also described.
|
|
WO/2016/031908A1 |
The purpose of the present invention is to provide an adsorbent for oral administration, said adsorbent being capable of adsorbing a large amount of indole in the presence of bile acid. The problem can be solved by providing the adsorben...
|
|
WO/2016/029158A3 |
In one embodiment, the present application discloses a method of reducing senescence in a mammal by reducing the concentration of non-ferritin iron within the mammal, comprising the administration of a therapeutically effective amount of...
|
|
WO/2016/024339A1 |
[Problem] To provide a cell repair agent capable of repairing cells that have been damaged due to the oxidizing power of substances such as acidic electrolyzed water, and a disinfection system capable of safely and efficiently facilitati...
|
|
WO/2016/020288A1 |
Disclosed are compounds active towards nuclear receptors, pharmaceutical compositions containing the compounds and use of the compounds in therapy.
|
|
WO/2016/011800A1 |
The present invention provides uses of a recombination ganoderma lucidum immunomodulatory protein (rLZ-8) in senescence delay medicines. According to the measurement of the content of the total protein, the growth hormone, the sex hormon...
|
|
WO/2016/005563A1 |
The present invention relates to a homeopathic agent allowing smokers to quit smoking, method for its production and its use as a medicament in smoking cessation therapy. The agent allowing smokers to quit smoking is characterized in tha...
|
|
WO/2016/001686A1 |
The invention relates to a succinate dehydrogenase inhibitor or a prodrug and/or a pharmaceutically acceptable salt thereof for use in the treatment or prevention of reperfusion injury, such as ischemia-reperfusion injury, by inhibiting ...
|
|
WO/2016/004418A1 |
Disclosed herein are methods of treating a subject having an altered NRF2/KEAP1 pathway, and compounds and compositions useful in such treatment. Also disclosed herein are methods of evaluating whether to administer a compound that inhib...
|
|
WO/2015/193716A1 |
The present invention relates to a phytochemical(s) rich herbal extract. In particular, the invention provides a flavonoid and phenolics rich extract from plant(s) belonging to family comprising but not limited to Elaeocarpaceae. The inv...
|
|
WO/2015/191827A1 |
A method for reducing muscle damage and/or oxidative stress in active mammals as disclosed. In one embodiment, the mammals are administered a carnitine supplement. The L-carnitine supplement may be administered without any other pharmace...
|
|
WO/2015/184545A1 |
The present disclosure provides a process for obtaining protein-enriched preparations from potatoes as well as such preparations comprising patatin and/or proteinase inhibitors. The process broadly comprises enzymatically treated de-star...
|
|
WO/2015/186806A1 |
Provided is a placenta extract that contains an active ingredient at a high concentration and is scarcely colored and, therefore, suitably usable for cosmetics and foods in which appearance and flavor are highly appreciated. The placenta...
|
|
WO/2015/180485A1 |
The present invention relates to an amantadine nitrate compound having a neuroprotective effect and a preparation and a medical use thereof. The compound has the structure of the general formula (I). The compound has multiple mechanisms ...
|
|
WO/2015/183963A3 |
Disclosed herein are methods and compositions for the treatment and/or prevention of diseases or conditions comprising administration of redox-active parabenzoquinones (RPBQs), and/or naturally or artificially occurring derivatives, anal...
|
|
WO/2015/181096A1 |
The invention provides an oral composition which can improve systemic symptoms such as sensitivity to cold. The oral composition includes, as its effective component, a red vine leaf extract to improve a symptom selected from the group c...
|
|
WO/2015/172400A1 |
A pharmaceutical composition for treating infertility, comprising the following raw materials: 10-20 parts by weight of radix rehmanniae preparata, 10-20 parts by weight of radix paeoniae alba, 10-20 parts by weight of cornus officinalis...
|
|
WO/2015/174475A1 |
Provided is a composition for oral intake, having improved oral absorption of curcumin and/or an analog thereof and being capable of being easily and inexpensively produced. A complex of curcumin and/or an analog thereof and a water-solu...
|
|
WO/2015/170605A1 |
The present invention addresses the problem of providing a food or drink that is capable of lowering the blood alcohol level after drinking an alcoholic beverage(s). To solve this problem, provided is a food or drink that contains water-...
|
|
WO/2015/161766A1 |
The present invention relates to a choline salt of a selenium-containing compound, and preparation method and use thereof. The structure of the selenium-containing compound choline salt of the present invention is as represented by formu...
|
